| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Michelle Stacy last filed a Form 4 in June 2024, as Director at IRBTQ. The filings on record cover 2 companies. Michelle Stacy's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 2,585 shares of DCOY. Net of sales, the DCOY filings show accumulation of 2,585 shares.
Michelle Stacy has 21 Form 4 filings on record from June 2015 to June 2024, across 2 companies: Director at Irobot (IRBTQ), 2015–2024; Director at Salarius Pharmaceuticals (DCOY), 2016–2018.
The 24 reported transactions were 10 stock awards, 7 open-market sales, 4 option or other derivative awards and 3 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $125K and 5 sales worth about $1.1M.
The largest open-market purchase was 3,000 shares of IRBTQ at an average $33.41 on March 15, 2016, about $100K.
The largest open-market sale was 4,000 shares of IRBTQ at an average $116.50 on January 25, 2021, about $466K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2021 | IRBTQ Irobot Corp | Director | Sell | 4,000 | $116.50 | $466,000.00 | -46.0% | |
| Jan 15, 2021 | IRBTQ Irobot Corp | Director | Sell | 1,000 | $92.00 | $92,000.00 | -8.3% | |
| Feb 27, 2019 | IRBTQ Irobot Corp | Director | Sell | 1,500 | $124.00 | $186,000.00 | -23.1% | |
| Feb 12, 2019 | IRBTQ Irobot Corp | Director | Sell | 1,500 | $114.00 | $171,000.00 | -18.8% | |
| Aug 22, 2018 | IRBTQ Irobot Corp | Director | Sell | 1,500 | $103.42 | $155,130.00 | -7.8% | |
| Mar 15, 2016 | IRBTQ Irobot Corp | Director | Buy | 3,000 | $33.41 | $100,230.00 | +30.0% | |
| Mar 15, 2016 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 2,585 | $9.63 | $24,893.55 | New |